In addition to the HLA-G heterogeneity caused by tumor cell itself, such as clonal growth with genetic alterations, epigenetic and post-translational modifications, explanation of HLA-G expression could be biased due to usage of different current available anti-HLA-G monoclonal antibodies, and different assay protocols (62, 96). This evidence concerns the gene HLA-G and neoplasm.